35 | | - | SECTION 1. Section 59A-22-41 NMSA 1978 (being Laws |
---|
36 | | - | 1997, Chapter 7, Section 1 and Laws 1997, Chapter 255, |
---|
37 | | - | Section 1, as amended) is amended to read: |
---|
| 56 | + | SECTION 1. Section 59A-22-41 NMSA 1978 (being Laws 1997, |
---|
| 57 | + | Chapter 7, Section 1 and Laws 1997, Chapter 255, Section 1, as |
---|
| 58 | + | amended) is amended to read: |
---|
42 | | - | this state shall provide coverage for individuals with |
---|
43 | | - | insulin-using diabetes, with non-insulin-using diabetes and |
---|
44 | | - | with elevated blood glucose levels induced by pregnancy. |
---|
45 | | - | This coverage shall be a basic health care benefit and shall |
---|
46 | | - | entitle each individual to the medically accepted standard of |
---|
47 | | - | medical care for diabetes and benefits for diabetes treatment |
---|
48 | | - | as well as diabetes supplies, and this coverage shall not be |
---|
49 | | - | reduced or eliminated. |
---|
50 | | - | B. Except as otherwise provided in this |
---|
51 | | - | subsection, coverage for individuals with diabetes may be HB 233/a |
---|
52 | | - | Page 2 |
---|
| 63 | + | this state shall provide coverage for individuals with insulin- |
---|
| 64 | + | .229151.1 underscored material = new |
---|
| 65 | + | [bracketed material] = delete |
---|
78 | | - | subject to deductibles and coinsurance consistent with those |
---|
79 | | - | imposed on other benefits under the same policy, plan or |
---|
80 | | - | certificate, as long as the annual deductibles or coinsurance |
---|
81 | | - | for benefits are no greater than the annual deductibles or |
---|
82 | | - | coinsurance established for similar benefits within a given |
---|
83 | | - | policy. The amount an individual with diabetes is required |
---|
84 | | - | to pay for a preferred formulary prescription insulin drug or |
---|
85 | | - | a medically necessary alternative is an amount not to exceed |
---|
86 | | - | a total of twenty-five dollars ($25.00) per thirty-day |
---|
87 | | - | supply. |
---|
| 91 | + | using diabetes, with non-insulin-using diabetes and with |
---|
| 92 | + | elevated blood glucose levels induced by pregnancy. This |
---|
| 93 | + | coverage shall be a basic health care benefit and shall entitle |
---|
| 94 | + | each individual to the medically accepted standard of medical |
---|
| 95 | + | care for diabetes and benefits for diabetes treatment as well |
---|
| 96 | + | as diabetes supplies, and this coverage shall not be reduced or |
---|
| 97 | + | eliminated. |
---|
| 98 | + | B. Except as otherwise provided in this subsection, |
---|
| 99 | + | coverage for individuals with diabetes may be subject to |
---|
| 100 | + | deductibles and coinsurance consistent with those imposed on |
---|
| 101 | + | other benefits under the same policy, plan or certificate, as |
---|
| 102 | + | long as the annual deductibles or coinsurance for benefits are |
---|
| 103 | + | no greater than the annual deductibles or coinsurance |
---|
| 104 | + | established for similar benefits within a given policy. The |
---|
| 105 | + | amount an individual with diabetes is required to pay for a |
---|
| 106 | + | preferred formulary prescription insulin drug or a medically |
---|
| 107 | + | necessary alternative is an amount not to exceed a total of |
---|
| 108 | + | twenty-five dollars ($25.00) per thirty-day supply. |
---|
95 | | - | for individuals with disabilities, including the legally |
---|
96 | | - | blind; |
---|
97 | | - | (2) test strips for blood glucose monitors; |
---|
98 | | - | (3) visual reading urine and ketone strips; |
---|
99 | | - | (4) lancets and lancet devices; |
---|
100 | | - | (5) insulin; |
---|
101 | | - | (6) injection aids, including those |
---|
102 | | - | adaptable to meet the needs of individuals with disabilities, HB 233/a |
---|
103 | | - | Page 3 |
---|
| 116 | + | .229151.1 |
---|
| 117 | + | - 2 - underscored material = new |
---|
| 118 | + | [bracketed material] = delete |
---|
129 | | - | including the legally blind; |
---|
| 144 | + | for individuals with disabilities, including the legally blind; |
---|
| 145 | + | (2) test strips for blood glucose monitors; |
---|
| 146 | + | (3) visual reading urine and ketone strips; |
---|
| 147 | + | (4) lancets and lancet devices; |
---|
| 148 | + | (5) insulin; |
---|
| 149 | + | (6) injection aids, including those adaptable |
---|
| 150 | + | to meet the needs of individuals with disabilities, including |
---|
| 151 | + | the legally blind; |
---|
133 | | - | (9) medically necessary podiatric appliances |
---|
134 | | - | for prevention of feet complications associated with |
---|
135 | | - | diabetes, including therapeutic molded or depth-inlay shoes, |
---|
136 | | - | functional orthotics, custom molded inserts, replacement |
---|
137 | | - | inserts, preventive devices and shoe modifications for |
---|
138 | | - | prevention and treatment; and |
---|
| 155 | + | (9) medically necessary: |
---|
| 156 | + | (a) podiatric appliances for prevention |
---|
| 157 | + | of feet complications associated with diabetes, including |
---|
| 158 | + | therapeutic molded or depth-inlay shoes, functional orthotics, |
---|
| 159 | + | custom molded inserts, replacement inserts, preventive devices |
---|
| 160 | + | and shoe modifications for prevention and treatment; and |
---|
| 161 | + | (b) durable medical equipment for the |
---|
| 162 | + | treatment of active diabetic foot ulcers, including topical |
---|
| 163 | + | oxygen therapy; and |
---|
142 | | - | diabetes as described in Subsection A of this section |
---|
143 | | - | enrolled in health policies described in that subsection |
---|
144 | | - | shall be entitled to the following basic health care |
---|
145 | | - | benefits: |
---|
146 | | - | (1) diabetes self-management training that |
---|
147 | | - | shall be provided by a certified, registered or licensed |
---|
148 | | - | health care professional with recent education in diabetes |
---|
149 | | - | management, which shall be limited to: |
---|
150 | | - | (a) medically necessary visits upon the |
---|
151 | | - | diagnosis of diabetes; |
---|
152 | | - | (b) visits following a diagnosis from a |
---|
153 | | - | health care practitioner that represents a significant change HB 233/a |
---|
154 | | - | Page 4 |
---|
| 167 | + | diabetes as described in Subsection A of this section enrolled |
---|
| 168 | + | in health policies described in that subsection shall be |
---|
| 169 | + | .229151.1 |
---|
| 170 | + | - 3 - underscored material = new |
---|
| 171 | + | [bracketed material] = delete |
---|
180 | | - | in the patient's symptoms or condition that warrants changes |
---|
181 | | - | in the patient's self-management; and |
---|
| 197 | + | entitled to the following basic health care benefits: |
---|
| 198 | + | (1) diabetes self-management training that |
---|
| 199 | + | shall be provided by a certified, registered or licensed health |
---|
| 200 | + | care professional with recent education in diabetes management, |
---|
| 201 | + | which shall be limited to: |
---|
| 202 | + | (a) medically necessary visits upon the |
---|
| 203 | + | diagnosis of diabetes; |
---|
| 204 | + | (b) visits following a diagnosis from a |
---|
| 205 | + | health care practitioner that represents a significant change |
---|
| 206 | + | in the patient's symptoms or condition that warrants changes in |
---|
| 207 | + | the patient's self-management; and |
---|
198 | | - | the equipment, appliances, prescription drug, insulin or |
---|
199 | | - | supplies described in this subsection within the limits of |
---|
200 | | - | the health care plan, policy or certificate. |
---|
201 | | - | F. An insurer that requires a covered person to |
---|
202 | | - | use a specific network provider or to purchase equipment, |
---|
203 | | - | appliances, supplies or insulin or prescription drugs for the |
---|
204 | | - | treatment or management of diabetes from a specific durable HB 233/a |
---|
205 | | - | Page 5 |
---|
| 222 | + | .229151.1 |
---|
| 223 | + | - 4 - underscored material = new |
---|
| 224 | + | [bracketed material] = delete |
---|
231 | | - | medical equipment supplier or other supplier as a condition |
---|
232 | | - | of coverage, payment or reimbursement shall: |
---|
| 250 | + | the equipment, appliances, prescription drug, insulin or |
---|
| 251 | + | supplies described in this subsection within the limits of the |
---|
| 252 | + | health care plan, policy or certificate. |
---|
| 253 | + | F. An insurer that requires a covered person to use |
---|
| 254 | + | a specific network provider or to purchase equipment, |
---|
| 255 | + | appliances, supplies or insulin or prescription drugs for the |
---|
| 256 | + | treatment or management of diabetes from a specific durable |
---|
| 257 | + | medical equipment supplier or other supplier as a condition of |
---|
| 258 | + | coverage, payment or reimbursement shall: |
---|
239 | | - | entire policy or plan period and shall not allow contracts |
---|
240 | | - | with network providers, durable medical equipment suppliers |
---|
241 | | - | and other suppliers to lapse or terminate without ensuring |
---|
242 | | - | the availability of a replacement and continuity of care; |
---|
243 | | - | provided that single-case agreements do not satisfy the |
---|
244 | | - | requirements of Paragraph (1) of this subsection or this |
---|
245 | | - | paragraph; |
---|
246 | | - | (3) monitor network providers, durable |
---|
247 | | - | medical equipment suppliers and other network suppliers to |
---|
248 | | - | ensure that medically necessary equipment, appliances, |
---|
249 | | - | supplies and insulin or other prescription drugs are being |
---|
250 | | - | delivered to a covered person in a timely manner and when |
---|
251 | | - | needed by the covered person; |
---|
252 | | - | (4) guarantee reimbursement to a covered |
---|
253 | | - | person within thirty days following receipt of a written |
---|
254 | | - | demand from the covered person who pays out of pocket for |
---|
255 | | - | necessary equipment, appliances, supplies and insulin or HB 233/a |
---|
256 | | - | Page 6 |
---|
| 265 | + | entire policy or plan period and shall not allow contracts with |
---|
| 266 | + | network providers, durable medical equipment suppliers and |
---|
| 267 | + | other suppliers to lapse or terminate without ensuring the |
---|
| 268 | + | availability of a replacement and continuity of care; provided |
---|
| 269 | + | that single-case agreements do not satisfy the requirements of |
---|
| 270 | + | Paragraph (1) of this subsection or this paragraph; |
---|
| 271 | + | (3) monitor network providers, durable medical |
---|
| 272 | + | equipment suppliers and other network suppliers to ensure that |
---|
| 273 | + | medically necessary equipment, appliances, supplies and insulin |
---|
| 274 | + | or other prescription drugs are being delivered to a covered |
---|
| 275 | + | .229151.1 |
---|
| 276 | + | - 5 - underscored material = new |
---|
| 277 | + | [bracketed material] = delete |
---|
282 | | - | other prescription drugs described in this section that are |
---|
283 | | - | not delivered timely to the covered person, and the portion |
---|
284 | | - | of payment for which the patient is responsible shall not |
---|
285 | | - | exceed the amount for the same covered benefit obtained from |
---|
286 | | - | a contracted supplier; |
---|
| 303 | + | person in a timely manner and when needed by the covered |
---|
| 304 | + | person; |
---|
| 305 | + | (4) guarantee reimbursement to a covered |
---|
| 306 | + | person within thirty days following receipt of a written demand |
---|
| 307 | + | from the covered person who pays out of pocket for necessary |
---|
| 308 | + | equipment, appliances, supplies and insulin or other |
---|
| 309 | + | prescription drugs described in this section that are not |
---|
| 310 | + | delivered timely to the covered person, and the portion of |
---|
| 311 | + | payment for which the patient is responsible shall not exceed |
---|
| 312 | + | the amount for the same covered benefit obtained from a |
---|
| 313 | + | contracted supplier; |
---|
287 | 314 | | (5) pay interest at the rate of eighteen |
---|
288 | 315 | | percent per year on the amount of reimbursement due to a |
---|
289 | 316 | | covered person if not paid within thirty days as required by |
---|
290 | 317 | | Paragraph (4) of this subsection; |
---|
291 | 318 | | (6) beginning on April 1, 2024, submit a |
---|
292 | 319 | | written report each quarter to the superintendent for the |
---|
293 | 320 | | previous quarter on the following metrics: |
---|
294 | 321 | | (a) the number of written demands for |
---|
295 | 322 | | reimbursement of out-of-pocket expenses from covered persons |
---|
296 | 323 | | received by the health care insurer; |
---|
297 | 324 | | (b) the number of out-of-pocket claims |
---|
298 | 325 | | for reimbursement paid and the aggregate amount of claims |
---|
299 | | - | reimbursed by the health care insurer within the time |
---|
300 | | - | required by Paragraph (4) of this subsection; |
---|
301 | | - | (c) the number of out-of-pocket claims |
---|
302 | | - | for reimbursement paid more than thirty days following |
---|
303 | | - | receipt of a written demand and the aggregate amount of these |
---|
304 | | - | payments, excluding interest; and |
---|
305 | | - | (d) the aggregate amount of interest |
---|
306 | | - | paid by the health care insurer pursuant to Paragraph (5) of HB 233/a |
---|
307 | | - | Page 7 |
---|
| 326 | + | reimbursed by the health care insurer within the time required |
---|
| 327 | + | by Paragraph (4) of this subsection; |
---|
| 328 | + | .229151.1 |
---|
| 329 | + | - 6 - underscored material = new |
---|
| 330 | + | [bracketed material] = delete |
---|
340 | 369 | | (a) the name, address and telephone |
---|
341 | 370 | | number of each supplier and, if applicable, the corresponding |
---|
342 | 371 | | date upon which the respective supplier's contract expired, |
---|
343 | 372 | | lapsed or was terminated during the previous quarter; |
---|
344 | 373 | | (b) the percentage of total deliveries, |
---|
345 | 374 | | by description of item, that did not meet the delivery |
---|
384 | | - | impose corrective action or use any other enforcement |
---|
385 | | - | mechanism available to the superintendent to obtain the |
---|
386 | | - | health care insurer's compliance with this section. |
---|
| 409 | + | health insurers offering policies, plans or certificates as |
---|
| 410 | + | described in Subsection A of this section for compliance with |
---|
| 411 | + | the requirements of this section. If the superintendent |
---|
| 412 | + | determines that a health care insurer has not complied with the |
---|
| 413 | + | requirements of this section, the superintendent shall impose |
---|
| 414 | + | corrective action or use any other enforcement mechanism |
---|
| 415 | + | available to the superintendent to obtain the health care |
---|
| 416 | + | insurer's compliance with this section. |
---|
393 | | - | health care practitioner. Changes in the prescribed dose of |
---|
394 | | - | a drug; quantities of supplies needed to administer a |
---|
395 | | - | prescribed drug; quantities of blood glucose self-testing |
---|
396 | | - | equipment and supplies; or quantities of supplies needed to |
---|
397 | | - | use or operate devices for which a covered person has |
---|
398 | | - | received prior authorization during the policy year shall not |
---|
399 | | - | be subject to additional prior authorization requirements in |
---|
400 | | - | the same policy year if prescribed as medically necessary by |
---|
401 | | - | the covered person's health care practitioner. Nothing in |
---|
402 | | - | this subsection shall be construed to require payment for |
---|
403 | | - | diabetes resources that are not covered benefits. |
---|
404 | | - | I. The provisions of this section do not apply to |
---|
405 | | - | short-term travel, accident-only or limited or specified |
---|
406 | | - | disease policies. |
---|
407 | | - | J. For purposes of this section: |
---|
408 | | - | (1) "basic health care benefits": HB 233/a |
---|
409 | | - | Page 9 |
---|
| 423 | + | health care practitioner. Changes in the prescribed dose of a |
---|
| 424 | + | drug; quantities of supplies needed to administer a prescribed |
---|
| 425 | + | drug; quantities of blood glucose self-testing equipment and |
---|
| 426 | + | supplies; or quantities of supplies needed to use or operate |
---|
| 427 | + | devices for which a covered person has received prior |
---|
| 428 | + | authorization during the policy year shall not be subject to |
---|
| 429 | + | additional prior authorization requirements in the same policy |
---|
| 430 | + | year if prescribed as medically necessary by the covered |
---|
| 431 | + | person's health care practitioner. Nothing in this subsection |
---|
| 432 | + | shall be construed to require payment for diabetes resources |
---|
| 433 | + | that are not covered benefits. |
---|
| 434 | + | .229151.1 |
---|
| 435 | + | - 8 - underscored material = new |
---|
| 436 | + | [bracketed material] = delete |
---|
435 | 467 | | (a) means benefits for medically |
---|
436 | 468 | | necessary services consisting of preventive care, emergency |
---|
437 | 469 | | care, inpatient and outpatient hospital and physician care, |
---|
438 | 470 | | diagnostic laboratory and diagnostic and therapeutic |
---|
439 | 471 | | radiological services; and |
---|
440 | 472 | | (b) does not include services for |
---|
441 | 473 | | alcohol or drug abuse, dental or long-term rehabilitation |
---|
442 | 474 | | treatment; and |
---|
443 | | - | (2) "managed health care plan" means a |
---|
444 | | - | health benefit plan offered by a health care insurer that |
---|
445 | | - | provides for the delivery of comprehensive basic health care |
---|
446 | | - | services and medically necessary services to individuals |
---|
447 | | - | enrolled in the plan through its own employed health care |
---|
448 | | - | providers or by contracting with selected or participating |
---|
449 | | - | health care providers. A managed health care plan includes |
---|
450 | | - | only those plans that provide comprehensive basic health care |
---|
451 | | - | services to enrollees on a prepaid, capitated basis, |
---|
452 | | - | including the following: |
---|
| 475 | + | (2) "managed health care plan" means a health |
---|
| 476 | + | benefit plan offered by a health care insurer that provides for |
---|
| 477 | + | the delivery of comprehensive basic health care services and |
---|
| 478 | + | medically necessary services to individuals enrolled in the |
---|
| 479 | + | plan through its own employed health care providers or by |
---|
| 480 | + | contracting with selected or participating health care |
---|
| 481 | + | providers. A managed health care plan includes only those |
---|
| 482 | + | plans that provide comprehensive basic health care services to |
---|
| 483 | + | enrollees on a prepaid, capitated basis, including the |
---|
| 484 | + | following: |
---|
494 | | - | A. Each group health insurance contract and |
---|
495 | | - | blanket health insurance contract delivered or issued for |
---|
496 | | - | delivery in this state shall provide coverage for individuals |
---|
497 | | - | with diabetes who use insulin, individuals with diabetes who |
---|
498 | | - | do not use insulin and with elevated blood glucose levels |
---|
499 | | - | induced by pregnancy. This coverage shall be a basic health |
---|
500 | | - | care benefit and shall entitle each individual to the |
---|
501 | | - | medically accepted standard of medical care for diabetes and |
---|
502 | | - | benefits for diabetes treatment as well as diabetes supplies, |
---|
503 | | - | and this coverage shall not be reduced or eliminated. |
---|
504 | | - | B. Except as otherwise provided in this |
---|
505 | | - | subsection, coverage for individuals with diabetes may be |
---|
506 | | - | subject to deductibles and coinsurance consistent with those |
---|
507 | | - | imposed on other benefits under the same policy, as long as |
---|
508 | | - | the annual deductibles or coinsurance for benefits are no |
---|
509 | | - | greater than the annual deductibles or coinsurance |
---|
510 | | - | established for similar benefits within a given policy. The HB 233/a |
---|
511 | | - | Page 11 |
---|
| 528 | + | A. Each group health insurance contract and blanket |
---|
| 529 | + | health insurance contract delivered or issued for delivery in |
---|
| 530 | + | this state shall provide coverage for individuals with diabetes |
---|
| 531 | + | who use insulin, individuals with diabetes who do not use |
---|
| 532 | + | insulin and with elevated blood glucose levels induced by |
---|
| 533 | + | pregnancy. This coverage shall be a basic health care benefit |
---|
| 534 | + | and shall entitle each individual to the medically accepted |
---|
| 535 | + | standard of medical care for diabetes and benefits for diabetes |
---|
| 536 | + | treatment as well as diabetes supplies, and this coverage shall |
---|
| 537 | + | not be reduced or eliminated. |
---|
| 538 | + | B. Except as otherwise provided in this subsection, |
---|
| 539 | + | coverage for individuals with diabetes may be subject to |
---|
| 540 | + | .229151.1 |
---|
| 541 | + | - 10 - underscored material = new |
---|
| 542 | + | [bracketed material] = delete |
---|
537 | | - | amount an individual with diabetes is required to pay for a |
---|
538 | | - | preferred formulary prescription insulin drug or a medically |
---|
539 | | - | necessary alternative is an amount not to exceed a total of |
---|
540 | | - | twenty-five dollars ($25.00) per thirty-day supply. |
---|
| 568 | + | deductibles and coinsurance consistent with those imposed on |
---|
| 569 | + | other benefits under the same policy, as long as the annual |
---|
| 570 | + | deductibles or coinsurance for benefits are no greater than the |
---|
| 571 | + | annual deductibles or coinsurance established for similar |
---|
| 572 | + | benefits within a given policy. The amount an individual with |
---|
| 573 | + | diabetes is required to pay for a preferred formulary |
---|
| 574 | + | prescription insulin drug or a medically necessary alternative |
---|
| 575 | + | is an amount not to exceed a total of twenty-five dollars |
---|
| 576 | + | ($25.00) per thirty-day supply. |
---|
588 | | - | functional orthotics, custom molded inserts, replacement |
---|
589 | | - | inserts, preventive devices and shoe modifications for |
---|
590 | | - | prevention and treatment; and |
---|
| 621 | + | (8) prescriptive oral agents for controlling |
---|
| 622 | + | blood sugar levels; |
---|
| 623 | + | (9) medically necessary: |
---|
| 624 | + | (a) podiatric appliances for prevention |
---|
| 625 | + | of feet complications associated with diabetes, including |
---|
| 626 | + | therapeutic molded or depth-inlay shoes, functional orthotics, |
---|
| 627 | + | custom molded inserts, replacement inserts, preventive devices |
---|
| 628 | + | and shoe modifications for prevention and treatment; and |
---|
| 629 | + | (b) durable medical equipment for the |
---|
| 630 | + | treatment of active diabetic foot ulcers, including topical |
---|
| 631 | + | oxygen therapy; and |
---|
606 | | - | in the patient's symptoms or condition that warrants changes |
---|
607 | | - | in the patient's self-management; and |
---|
608 | | - | (c) visits when re-education or |
---|
609 | | - | refresher training is prescribed by a health care |
---|
610 | | - | practitioner with prescribing authority; |
---|
611 | | - | (2) medical nutrition therapy related to |
---|
612 | | - | diabetes management; and HB 233/a |
---|
613 | | - | Page 13 |
---|
| 646 | + | .229151.1 |
---|
| 647 | + | - 12 - underscored material = new |
---|
| 648 | + | [bracketed material] = delete |
---|
639 | | - | (3) medically necessary treatment of active |
---|
640 | | - | diabetic foot ulcers, including topical oxygen therapy. |
---|
| 674 | + | in the patient's symptoms or condition that warrants changes in |
---|
| 675 | + | the patient's self-management; and |
---|
| 676 | + | (c) visits when re-education or |
---|
| 677 | + | refresher training is prescribed by a health care practitioner |
---|
| 678 | + | with prescribing authority; and |
---|
| 679 | + | (2) medical nutrition therapy related to |
---|
| 680 | + | diabetes management. |
---|
651 | | - | supplies described in this subsection within the limits of |
---|
652 | | - | the health care plan, policy or certificate. |
---|
653 | | - | F. An insurer that requires a covered person to |
---|
654 | | - | use a specific network provider or to purchase equipment, |
---|
| 691 | + | supplies described in this subsection within the limits of the |
---|
| 692 | + | health care plan, policy or certificate. |
---|
| 693 | + | F. An insurer that requires a covered person to use |
---|
| 694 | + | a specific network provider or to purchase equipment, |
---|
657 | | - | medical equipment supplier or other supplier as a condition |
---|
658 | | - | of coverage, payment or reimbursement shall: |
---|
659 | | - | (1) maintain an adequate network of durable |
---|
660 | | - | medical equipment suppliers and other suppliers to provide |
---|
661 | | - | covered persons with medically necessary diabetes resources |
---|
662 | | - | whether covered under the health policy's prescription drug |
---|
663 | | - | or medical benefit; HB 233/a |
---|
664 | | - | Page 14 |
---|
| 697 | + | medical equipment supplier or other supplier as a condition of |
---|
| 698 | + | coverage, payment or reimbursement shall: |
---|
| 699 | + | .229151.1 |
---|
| 700 | + | - 13 - underscored material = new |
---|
| 701 | + | [bracketed material] = delete |
---|
691 | | - | entire policy or plan period and shall not allow contracts |
---|
692 | | - | with network providers, durable medical equipment suppliers |
---|
693 | | - | and other suppliers to lapse or terminate without ensuring |
---|
694 | | - | the availability of a replacement and continuity of care; |
---|
695 | | - | provided that single-case agreements do not satisfy the |
---|
696 | | - | requirements of Paragraph (1) of this subsection or this |
---|
697 | | - | paragraph; |
---|
698 | | - | (3) monitor network providers, durable |
---|
699 | | - | medical equipment suppliers and other network suppliers to |
---|
700 | | - | ensure that medically necessary equipment, appliances, |
---|
701 | | - | supplies and insulin or other prescription drugs are being |
---|
702 | | - | delivered to a covered person in a timely manner and when |
---|
703 | | - | needed by the covered person; |
---|
| 733 | + | entire policy or plan period and shall not allow contracts with |
---|
| 734 | + | network providers, durable medical equipment suppliers and |
---|
| 735 | + | other suppliers to lapse or terminate without ensuring the |
---|
| 736 | + | availability of a replacement and continuity of care; provided |
---|
| 737 | + | that single-case agreements do not satisfy the requirements of |
---|
| 738 | + | Paragraph (1) of this subsection or this paragraph; |
---|
| 739 | + | (3) monitor network providers, durable medical |
---|
| 740 | + | equipment suppliers and other network suppliers to ensure that |
---|
| 741 | + | medically necessary equipment, appliances, supplies and insulin |
---|
| 742 | + | or other prescription drugs are being delivered to a covered |
---|
| 743 | + | person in a timely manner and when needed by the covered |
---|
| 744 | + | person; |
---|
705 | | - | person within thirty days following receipt of a written |
---|
706 | | - | demand from the covered person who pays out of pocket for |
---|
707 | | - | necessary equipment, appliances, supplies and insulin or |
---|
708 | | - | other prescription drugs described in this section that are |
---|
709 | | - | not delivered in a timely manner to the covered person, and |
---|
710 | | - | the portion of payment for which the patient is responsible |
---|
711 | | - | shall not exceed the amount for the same covered benefit |
---|
712 | | - | obtained from a contracted supplier; |
---|
713 | | - | (5) pay interest at the rate of eighteen |
---|
714 | | - | percent per year on the amount of reimbursement due to a HB 233/a |
---|
715 | | - | Page 15 |
---|
| 746 | + | person within thirty days following receipt of a written demand |
---|
| 747 | + | from the covered person who pays out of pocket for necessary |
---|
| 748 | + | equipment, appliances, supplies and insulin or other |
---|
| 749 | + | prescription drugs described in this section that are not |
---|
| 750 | + | delivered in a timely manner to the covered person and the |
---|
| 751 | + | portion of payment for which the patient is responsible shall |
---|
| 752 | + | .229151.1 |
---|
| 753 | + | - 14 - underscored material = new |
---|
| 754 | + | [bracketed material] = delete |
---|
741 | 784 | | covered person if not paid within thirty days as required by |
---|
742 | 785 | | Paragraph (4) of this subsection; |
---|
743 | 786 | | (6) beginning on April 1, 2024, submit a |
---|
744 | 787 | | written report each quarter to the superintendent for the |
---|
745 | 788 | | previous quarter on the following metrics: |
---|
746 | 789 | | (a) the number of written demands for |
---|
747 | 790 | | reimbursement of out-of-pocket expenses from covered persons |
---|
748 | 791 | | received by the health care insurer; |
---|
749 | 792 | | (b) the number of out-of-pocket claims |
---|
750 | 793 | | for reimbursement paid and the aggregate amount of claims |
---|
792 | 837 | | (a) the name, address and telephone |
---|
793 | 838 | | number of each supplier and, if applicable, the corresponding |
---|
794 | 839 | | date upon which the respective supplier's contract expired, |
---|
795 | 840 | | lapsed or was terminated during the previous quarter; |
---|
796 | 841 | | (b) the percentage of total deliveries, |
---|
797 | 842 | | by description of item, that did not meet the delivery |
---|
808 | | - | determines that a health care insurer has not complied with |
---|
809 | | - | the requirements of this section, the superintendent shall |
---|
810 | | - | impose corrective action or use any other enforcement |
---|
811 | | - | mechanism available to the superintendent to obtain the |
---|
812 | | - | health care insurer's compliance with this section. |
---|
| 852 | + | determines that a health care insurer has not complied with the |
---|
| 853 | + | requirements of this section, the superintendent shall impose |
---|
| 854 | + | corrective action or use any other enforcement mechanism |
---|
| 855 | + | available to the superintendent to obtain the health care |
---|
| 856 | + | insurer's compliance with this section. |
---|
845 | | - | health care practitioner. Changes in the prescribed dose of |
---|
846 | | - | a drug; quantities of supplies needed to administer a |
---|
847 | | - | prescribed drug; quantities of blood glucose self-testing |
---|
848 | | - | equipment and supplies; or quantities of supplies needed to |
---|
849 | | - | use or operate devices for which a covered person has |
---|
850 | | - | received prior authorization during the policy year shall not |
---|
851 | | - | be subject to additional prior authorization requirements in |
---|
852 | | - | the same policy year if prescribed as medically necessary by |
---|
853 | | - | the covered person's health care practitioner. Nothing in |
---|
854 | | - | this subsection shall be construed to require payment for |
---|
855 | | - | diabetes resources that are not covered benefits. |
---|
| 891 | + | health care practitioner. Changes in the prescribed dose of a |
---|
| 892 | + | drug; quantities of supplies needed to administer a prescribed |
---|
| 893 | + | drug; quantities of blood glucose self-testing equipment and |
---|
| 894 | + | supplies; or quantities of supplies needed to use or operate |
---|
| 895 | + | devices for which a covered person has received prior |
---|
| 896 | + | authorization during the policy year shall not be subject to |
---|
| 897 | + | additional prior authorization requirements in the same policy |
---|
| 898 | + | year if prescribed as medically necessary by the covered |
---|
| 899 | + | person's health care practitioner. Nothing in this subsection |
---|
| 900 | + | shall be construed to require payment for diabetes resources |
---|
| 901 | + | that are not covered benefits. |
---|
894 | | - | SECTION 3. Section 59A-46-43 NMSA 1978 (being Laws |
---|
895 | | - | 1997, Chapter 7, Section 3 and Laws 1997, Chapter 255, |
---|
896 | | - | Section 3, as amended) is amended to read: |
---|
| 939 | + | radiological services; and |
---|
| 940 | + | (2) does not include services for alcohol or |
---|
| 941 | + | drug abuse, dental or long-term rehabilitation treatment." |
---|
| 942 | + | SECTION 3. Section 59A-46-43 NMSA 1978 (being Laws 1997, |
---|
| 943 | + | Chapter 7, Section 3 and Laws 1997, Chapter 255, Section 3, as |
---|
| 944 | + | amended) is amended to read: |
---|
899 | | - | organization contract delivered or issued for delivery in |
---|
900 | | - | this state shall provide coverage for individuals with |
---|
901 | | - | insulin-using diabetes, with non-insulin-using diabetes and |
---|
902 | | - | with elevated blood glucose levels induced by pregnancy. |
---|
903 | | - | This coverage shall be a basic health care service and shall |
---|
904 | | - | entitle each individual to the medically accepted standard of |
---|
905 | | - | medical care for diabetes and benefits for diabetes treatment |
---|
906 | | - | as well as diabetes supplies, and this coverage shall not be |
---|
907 | | - | reduced or eliminated. |
---|
| 947 | + | organization contract delivered or issued for delivery in this |
---|
| 948 | + | state shall provide coverage for individuals with insulin-using |
---|
| 949 | + | diabetes, with non-insulin-using diabetes and with elevated |
---|
| 950 | + | blood glucose levels induced by pregnancy. This coverage shall |
---|
| 951 | + | be a basic health care service and shall entitle each |
---|
| 952 | + | individual to the medically accepted standard of medical care |
---|
| 953 | + | for diabetes and benefits for diabetes treatment as well as |
---|
| 954 | + | diabetes supplies, and this coverage shall not be reduced or |
---|
| 955 | + | eliminated. |
---|
909 | | - | for individuals with diabetes may be subject to deductibles |
---|
910 | | - | and coinsurance consistent with those imposed on other |
---|
911 | | - | benefits under the same contract, as long as the annual |
---|
912 | | - | deductibles or coinsurance for benefits are no greater than |
---|
913 | | - | the annual deductibles or coinsurance established for similar |
---|
914 | | - | benefits within a given contract. The amount an individual |
---|
915 | | - | with diabetes is required to pay for a preferred formulary |
---|
916 | | - | prescription insulin drug or a medically necessary |
---|
917 | | - | alternative is an amount not to exceed a total of twenty-five |
---|
918 | | - | dollars ($25.00) per thirty-day supply. HB 233/a |
---|
919 | | - | Page 19 |
---|
| 957 | + | for individuals with diabetes may be subject to deductibles and |
---|
| 958 | + | coinsurance consistent with those imposed on other benefits |
---|
| 959 | + | under the same contract, as long as the annual deductibles or |
---|
| 960 | + | coinsurance for benefits are no greater than the annual |
---|
| 961 | + | deductibles or coinsurance established for similar benefits |
---|
| 962 | + | within a given contract. The amount an individual with |
---|
| 963 | + | diabetes is required to pay for a preferred formulary |
---|
| 964 | + | .229151.1 |
---|
| 965 | + | - 18 - underscored material = new |
---|
| 966 | + | [bracketed material] = delete |
---|
947 | | - | diabetes as described in Subsection A of this section |
---|
948 | | - | enrolled under an individual or group health maintenance |
---|
949 | | - | organization contract shall be entitled to the following |
---|
950 | | - | equipment, supplies and appliances to treat diabetes: |
---|
| 997 | + | diabetes as described in Subsection A of this section enrolled |
---|
| 998 | + | under an individual or group health maintenance organization |
---|
| 999 | + | contract shall be entitled to the following equipment, supplies |
---|
| 1000 | + | and appliances to treat diabetes: |
---|
964 | | - | (9) medically necessary podiatric appliances |
---|
965 | | - | for prevention of feet complications associated with |
---|
966 | | - | diabetes, including therapeutic molded or depth-inlay shoes, |
---|
967 | | - | functional orthotics, custom molded inserts, replacement |
---|
968 | | - | inserts, preventive devices and shoe modifications for |
---|
969 | | - | prevention and treatment; and HB 233/a |
---|
970 | | - | Page 20 |
---|
| 1013 | + | (9) medically necessary: |
---|
| 1014 | + | (a) podiatric appliances for prevention |
---|
| 1015 | + | of feet complications associated with diabetes, including |
---|
| 1016 | + | therapeutic molded or depth-inlay shoes, functional orthotics, |
---|
| 1017 | + | .229151.1 |
---|
| 1018 | + | - 19 - underscored material = new |
---|
| 1019 | + | [bracketed material] = delete |
---|
1047 | | - | federal food and drug administration, each individual or |
---|
1048 | | - | group health maintenance organization contract shall: |
---|
1049 | | - | (1) maintain an adequate formulary to |
---|
1050 | | - | provide these resources to individuals with diabetes; and |
---|
| 1098 | + | diabetes management. |
---|
| 1099 | + | E. When new or improved equipment, appliances, |
---|
| 1100 | + | prescription drugs for the treatment of diabetes, insulin or |
---|
| 1101 | + | supplies for the treatment of diabetes are approved by the |
---|
| 1102 | + | federal food and drug administration, each individual or group |
---|
| 1103 | + | health maintenance organization contract shall: |
---|
| 1104 | + | (1) maintain an adequate formulary to provide |
---|
| 1105 | + | these resources to individuals with diabetes; and |
---|
1055 | 1110 | | F. A health maintenance organization that requires |
---|
1056 | 1111 | | an enrollee to use a specific network provider or to purchase |
---|
1057 | 1112 | | equipment, appliances, supplies or insulin or prescription |
---|
1058 | 1113 | | drugs for the treatment or management of diabetes from a |
---|
1059 | 1114 | | specific durable medical equipment supplier or other supplier |
---|
1060 | 1115 | | as a condition of coverage, payment or reimbursement shall: |
---|
1061 | 1116 | | (1) maintain an adequate network of durable |
---|
1062 | 1117 | | medical equipment suppliers and other suppliers to provide |
---|
1063 | 1118 | | covered persons with medically necessary diabetes resources |
---|
1064 | 1119 | | whether covered under the health maintenance organization |
---|
1065 | 1120 | | contract's prescription drug or medical benefit; |
---|
1066 | 1121 | | (2) have network contracts in place for the |
---|
1067 | 1122 | | entire contract period and shall not allow contracts with |
---|
1098 | | - | requirements of Paragraph (1) of this subsection or this |
---|
1099 | | - | paragraph; |
---|
1100 | | - | (3) monitor network providers, durable |
---|
1101 | | - | medical equipment suppliers and other network suppliers to |
---|
1102 | | - | ensure that medically necessary equipment, appliances, |
---|
1103 | | - | supplies and insulin or other prescription drugs are being |
---|
1104 | | - | delivered to an enrollee in a timely manner and when needed |
---|
1105 | | - | by the enrollee; |
---|
| 1151 | + | network providers, durable medical equipment suppliers and |
---|
| 1152 | + | other suppliers to lapse or terminate without ensuring the |
---|
| 1153 | + | availability of a replacement and continuity of care; provided |
---|
| 1154 | + | that single-case agreements do not satisfy the requirements of |
---|
| 1155 | + | Paragraph (1) of this subsection or this paragraph; |
---|
| 1156 | + | (3) monitor network providers, durable medical |
---|
| 1157 | + | equipment suppliers and other network suppliers to ensure that |
---|
| 1158 | + | medically necessary equipment, appliances, supplies and insulin |
---|
| 1159 | + | or other prescription drugs are being delivered to an enrollee |
---|
| 1160 | + | in a timely manner and when needed by the enrollee; |
---|
1110 | | - | described in this section that are not delivered timely to |
---|
1111 | | - | the enrollee, and the portion of payment for which the |
---|
1112 | | - | patient is responsible shall not exceed the amount for the |
---|
1113 | | - | same covered benefit obtained from a contracted supplier; |
---|
| 1165 | + | described in this section that are not delivered timely to the |
---|
| 1166 | + | enrollee and the portion of payment for which the patient is |
---|
| 1167 | + | responsible shall not exceed the amount for the same covered |
---|
| 1168 | + | benefit obtained from a contracted supplier; |
---|
1163 | | - | superintendent with the following information for each |
---|
1164 | | - | durable medical equipment supplier or other supplier that was |
---|
1165 | | - | under contract with the health maintenance organization or |
---|
1166 | | - | its agent during the previous quarter: |
---|
| 1220 | + | superintendent with the following information for each durable |
---|
| 1221 | + | medical equipment supplier or other supplier that was under |
---|
| 1222 | + | contract with the health maintenance organization or its agent |
---|
| 1223 | + | during the previous quarter: |
---|
1200 | | - | and |
---|
1201 | | - | (c) the number of complaints received |
---|
1202 | | - | by the health maintenance organization or its agent during |
---|
1203 | | - | the previous quarter related to late deliveries, incomplete |
---|
1204 | | - | orders or incorrect orders, respectively. |
---|
| 1257 | + | by description of item, that did not meet the delivery |
---|
| 1258 | + | requirements specified in Paragraph (3) of this subsection; and |
---|
| 1259 | + | (c) the number of complaints received by |
---|
| 1260 | + | the health maintenance organization or its agent during the |
---|
| 1261 | + | previous quarter related to late deliveries, incomplete orders |
---|
| 1262 | + | or incorrect orders, respectively. |
---|
1211 | | - | superintendent shall impose corrective action or use any |
---|
1212 | | - | other enforcement mechanism available to the superintendent |
---|
1213 | | - | to obtain the health maintenance organization's compliance |
---|
1214 | | - | with this section. |
---|
1215 | | - | H. Absent a change in diagnosis or in an |
---|
1216 | | - | enrollee's management or treatment of diabetes or its |
---|
1217 | | - | complications, a health maintenance organization shall not |
---|
1218 | | - | require more than one prior authorization per policy period |
---|
1219 | | - | for any single drug or category of item enumerated in this |
---|
1220 | | - | section if prescribed as medically necessary by the |
---|
1221 | | - | enrollee's health care practitioner. Changes in the |
---|
1222 | | - | prescribed dose of a drug; quantities of supplies needed to |
---|
1223 | | - | administer a prescribed drug; quantities of blood glucose |
---|
1224 | | - | self-testing equipment and supplies; or quantities of HB 233/a |
---|
1225 | | - | Page 25 |
---|
| 1269 | + | superintendent shall impose corrective action or use any other |
---|
| 1270 | + | enforcement mechanism available to the superintendent to obtain |
---|
| 1271 | + | the health maintenance organization's compliance with this |
---|
| 1272 | + | section. |
---|
| 1273 | + | H. Absent a change in diagnosis or in an enrollee's |
---|
| 1274 | + | management or treatment of diabetes or its complications, a |
---|
| 1275 | + | health maintenance organization shall not require more than one |
---|
| 1276 | + | prior authorization per policy period for any single drug or |
---|
| 1277 | + | category of item enumerated in this section if prescribed as |
---|
| 1278 | + | medically necessary by the enrollee's health care practitioner. |
---|
| 1279 | + | Changes in the prescribed dose of a drug; quantities of |
---|
| 1280 | + | supplies needed to administer a prescribed drug; quantities of |
---|
| 1281 | + | blood glucose self-testing equipment and supplies; or |
---|
| 1282 | + | .229151.1 |
---|
| 1283 | + | - 24 - underscored material = new |
---|
| 1284 | + | [bracketed material] = delete |
---|
1251 | | - | supplies needed to use or operate devices for which an |
---|
1252 | | - | enrollee has received prior authorization during the policy |
---|
1253 | | - | year shall not be subject to additional prior authorization |
---|
1254 | | - | requirements in the same policy year if prescribed as |
---|
1255 | | - | medically necessary by the enrollee's health care |
---|
1256 | | - | practitioner. Nothing in this subsection shall be construed |
---|
1257 | | - | to require payment for diabetes resources that are not a |
---|
1258 | | - | covered benefit. |
---|
| 1310 | + | quantities of supplies needed to use or operate devices for |
---|
| 1311 | + | which an enrollee has received prior authorization during the |
---|
| 1312 | + | policy year shall not be subject to additional prior |
---|
| 1313 | + | authorization requirements in the same policy year if |
---|
| 1314 | + | prescribed as medically necessary by the enrollee's health care |
---|
| 1315 | + | practitioner. Nothing in this subsection shall be construed to |
---|
| 1316 | + | require payment for diabetes resources that are not a covered |
---|
| 1317 | + | benefit. |
---|
1264 | 1323 | | (1) means benefits for medically necessary |
---|
1265 | 1324 | | services consisting of preventive care, emergency care, |
---|
1266 | 1325 | | inpatient and outpatient hospital and physician care, |
---|
1267 | 1326 | | diagnostic laboratory and diagnostic and therapeutic |
---|
1268 | 1327 | | radiological services; and |
---|
1269 | 1328 | | (2) does not include services for alcohol or |
---|
1270 | 1329 | | drug abuse, dental or long-term rehabilitation treatment." |
---|
1271 | 1330 | | SECTION 4. Section 59A-47-45.8 NMSA 1978 (being Laws |
---|
1272 | 1331 | | 2023, Chapter 50, Section 5) is amended to read: |
---|
1273 | 1332 | | "59A-47-45.8. COVERAGE FOR INDIVIDUALS WITH DIABETES.-- |
---|
1274 | 1333 | | A. Each health care plan delivered or issued for |
---|
1302 | | - | with diabetes who use insulin, individuals with diabetes who |
---|
1303 | | - | do not use insulin and with elevated blood glucose levels |
---|
1304 | | - | induced by pregnancy. This coverage shall be a basic health |
---|
1305 | | - | care benefit and shall entitle each individual to the |
---|
1306 | | - | medically accepted standard of medical care for diabetes and |
---|
1307 | | - | benefits for diabetes treatment as well as diabetes supplies, |
---|
1308 | | - | and this coverage shall not be reduced or eliminated. |
---|
1309 | | - | B. Except as otherwise provided in this |
---|
1310 | | - | subsection, coverage for individuals with diabetes may be |
---|
1311 | | - | subject to deductibles and coinsurance consistent with those |
---|
1312 | | - | imposed on other benefits under the same plan as long as the |
---|
1313 | | - | annual deductibles or coinsurance for benefits are no greater |
---|
1314 | | - | than the annual deductibles or coinsurance established for |
---|
1315 | | - | similar benefits within a given plan. The amount an |
---|
1316 | | - | individual with diabetes is required to pay for a preferred |
---|
1317 | | - | formulary prescription insulin drug or a medically necessary |
---|
1318 | | - | alternative is an amount not to exceed a total of twenty-five |
---|
1319 | | - | dollars ($25.00) per thirty-day supply. |
---|
| 1363 | + | with diabetes who use insulin, individuals with diabetes who do |
---|
| 1364 | + | not use insulin and with elevated blood glucose levels induced |
---|
| 1365 | + | by pregnancy. This coverage shall be a basic health care |
---|
| 1366 | + | benefit and shall entitle each individual to the medically |
---|
| 1367 | + | accepted standard of medical care for diabetes and benefits for |
---|
| 1368 | + | diabetes treatment as well as diabetes supplies, and this |
---|
| 1369 | + | coverage shall not be reduced or eliminated. |
---|
| 1370 | + | B. Except as otherwise provided in this subsection, |
---|
| 1371 | + | coverage for individuals with diabetes may be subject to |
---|
| 1372 | + | deductibles and coinsurance consistent with those imposed on |
---|
| 1373 | + | other benefits under the same plan as long as the annual |
---|
| 1374 | + | deductibles or coinsurance for benefits are no greater than the |
---|
| 1375 | + | annual deductibles or coinsurance established for similar |
---|
| 1376 | + | benefits within a given plan. The amount an individual with |
---|
| 1377 | + | diabetes is required to pay for a preferred formulary |
---|
| 1378 | + | prescription insulin drug or a medically necessary alternative |
---|
| 1379 | + | is an amount not to exceed a total of twenty-five dollars |
---|
| 1380 | + | ($25.00) per thirty-day supply. |
---|
1322 | | - | diabetes as described in Subsection A of this section |
---|
1323 | | - | enrolled in health care plans described in that subsection |
---|
1324 | | - | shall be entitled to the following equipment, supplies and |
---|
1325 | | - | appliances to treat diabetes: |
---|
1326 | | - | (1) blood glucose monitors, including those HB 233/a |
---|
1327 | | - | Page 27 |
---|
| 1383 | + | diabetes as described in Subsection A of this section enrolled |
---|
| 1384 | + | in health care plans described in that subsection shall be |
---|
| 1385 | + | entitled to the following equipment, supplies and appliances to |
---|
| 1386 | + | treat diabetes: |
---|
| 1387 | + | (1) blood glucose monitors, including those |
---|
| 1388 | + | .229151.1 |
---|
| 1389 | + | - 26 - underscored material = new |
---|
| 1390 | + | [bracketed material] = delete |
---|
1364 | | - | (9) medically necessary podiatric appliances |
---|
1365 | | - | for prevention of feet complications associated with |
---|
1366 | | - | diabetes, including therapeutic molded or depth-inlay shoes, |
---|
1367 | | - | functional orthotics, custom molded inserts, replacement |
---|
1368 | | - | inserts, preventive devices and shoe modifications for |
---|
1369 | | - | prevention and treatment; and |
---|
| 1427 | + | (9) medically necessary: |
---|
| 1428 | + | (a) podiatric appliances for prevention |
---|
| 1429 | + | of feet complications associated with diabetes, including |
---|
| 1430 | + | therapeutic molded or depth-inlay shoes, functional orthotics, |
---|
| 1431 | + | custom molded inserts, replacement inserts, preventive devices |
---|
| 1432 | + | and shoe modifications for prevention and treatment; and |
---|
| 1433 | + | (b) durable medical equipment for the |
---|
| 1434 | + | treatment of active diabetic foot ulcers, including topical |
---|
| 1435 | + | oxygen therapy; and |
---|
1404 | | - | shall be provided by a certified, registered or licensed |
---|
1405 | | - | health care professional with recent education in diabetes |
---|
1406 | | - | management, which shall be limited to: |
---|
| 1469 | + | entitled to the following basic health care benefits: |
---|
| 1470 | + | (1) diabetes self-management training that |
---|
| 1471 | + | shall be provided by a certified, registered or licensed health |
---|
| 1472 | + | care professional with recent education in diabetes management, |
---|
| 1473 | + | which shall be limited to: |
---|
1423 | | - | federal food and drug administration, all health care plans |
---|
1424 | | - | as described in Subsection A of this section shall: |
---|
1425 | | - | (1) maintain an adequate formulary to |
---|
1426 | | - | provide those resources to individuals with diabetes; and |
---|
| 1488 | + | federal food and drug administration, all health care plans as |
---|
| 1489 | + | described in Subsection A of this section shall: |
---|
| 1490 | + | (1) maintain an adequate formulary to provide |
---|
| 1491 | + | those resources to individuals with diabetes; and |
---|
1472 | | - | availability of a replacement and continuity of care; |
---|
1473 | | - | provided that single-case agreements do not satisfy the |
---|
1474 | | - | requirements of Paragraph (1) of this subsection or this |
---|
1475 | | - | paragraph; |
---|
1476 | | - | (3) monitor network providers, durable |
---|
1477 | | - | medical equipment suppliers and other network suppliers to |
---|
1478 | | - | ensure that medically necessary equipment, appliances, |
---|
1479 | | - | supplies and insulin or other prescription drugs are being HB 233/a |
---|
1480 | | - | Page 30 |
---|
| 1539 | + | availability of a replacement and continuity of care; provided |
---|
| 1540 | + | that single-case agreements do not satisfy the requirements of |
---|
| 1541 | + | Paragraph (1) of this subsection or this paragraph; |
---|
| 1542 | + | (3) monitor network providers, durable medical |
---|
| 1543 | + | equipment suppliers and other network suppliers to ensure that |
---|
| 1544 | + | medically necessary equipment, appliances, supplies and insulin |
---|
| 1545 | + | or other prescription drugs are being delivered to a subscriber |
---|
| 1546 | + | in a timely manner and when needed by the subscriber; |
---|
| 1547 | + | .229151.1 |
---|
| 1548 | + | - 29 - underscored material = new |
---|
| 1549 | + | [bracketed material] = delete |
---|
1510 | | - | the subscriber who pays out of pocket for necessary |
---|
1511 | | - | equipment, appliances, supplies and insulin or other |
---|
1512 | | - | prescription drugs described in this section that are not |
---|
1513 | | - | delivered timely to the subscriber and the portion of payment |
---|
1514 | | - | for which the patient is responsible shall not exceed the |
---|
1515 | | - | amount for the same covered benefit obtained from a |
---|
1516 | | - | contracted supplier; |
---|
| 1577 | + | the subscriber who pays out of pocket for necessary equipment, |
---|
| 1578 | + | appliances, supplies and insulin or other prescription drugs |
---|
| 1579 | + | described in this section that are not delivered timely to the |
---|
| 1580 | + | subscriber and the portion of payment for which the patient is |
---|
| 1581 | + | responsible shall not exceed the amount for the same covered |
---|
| 1582 | + | benefit obtained from a contracted supplier; |
---|
1517 | 1583 | | (5) pay interest at the rate of eighteen |
---|
1518 | 1584 | | percent per year on the amount of reimbursement due to a |
---|
1519 | 1585 | | subscriber if not paid within thirty days as required by |
---|
1520 | 1586 | | Paragraph (4) of this subsection; |
---|
1521 | 1587 | | (6) beginning on April 1, 2024, submit a |
---|
1522 | 1588 | | written report each quarter to the superintendent for the |
---|
1523 | 1589 | | previous quarter on the following metrics: |
---|
1524 | 1590 | | (a) the number of written demands for |
---|
1525 | 1591 | | reimbursement of out-of-pocket expenses from subscribers |
---|
1526 | 1592 | | received by the health care plan; |
---|
1527 | 1593 | | (b) the number of out-of-pocket claims |
---|
1528 | 1594 | | for reimbursement paid and the aggregate amount of claims |
---|
1529 | | - | reimbursed by the health care plan within the time required |
---|
1530 | | - | by Paragraph (4) of this subsection; HB 233/a |
---|
1531 | | - | Page 31 |
---|
| 1595 | + | reimbursed by the health care plan within the time required by |
---|
| 1596 | + | Paragraph (4) of this subsection; |
---|
| 1597 | + | (c) the number of out-of-pocket claims |
---|
| 1598 | + | for reimbursement paid more than thirty days following receipt |
---|
| 1599 | + | of a written demand and the aggregate amount of these payments, |
---|
| 1600 | + | .229151.1 |
---|
| 1601 | + | - 30 - underscored material = new |
---|
| 1602 | + | [bracketed material] = delete |
---|
1570 | 1638 | | (a) the name, address and telephone |
---|
1571 | 1639 | | number of each supplier and, if applicable, the corresponding |
---|
1572 | 1640 | | date upon which the respective supplier's contract expired, |
---|
1573 | 1641 | | lapsed or was terminated during the previous quarter; |
---|
1574 | 1642 | | (b) the percentage of total deliveries, |
---|
1575 | 1643 | | by description of item, that did not meet the delivery |
---|
1576 | | - | requirements specified in Paragraph (3) of this subsection; |
---|
1577 | | - | and |
---|
1578 | | - | (c) the number of complaints received |
---|
1579 | | - | by the health care plan or its agent during the previous |
---|
1580 | | - | quarter related to late deliveries, incomplete orders or |
---|
1581 | | - | incorrect orders, respectively. HB 233/a |
---|
1582 | | - | Page 32 |
---|
| 1644 | + | requirements specified in Paragraph (3) of this subsection; and |
---|
| 1645 | + | (c) the number of complaints received by |
---|
| 1646 | + | the health care plan or its agent during the previous quarter |
---|
| 1647 | + | related to late deliveries, incomplete orders or incorrect |
---|
| 1648 | + | orders, respectively. |
---|
| 1649 | + | G. The superintendent shall annually audit all |
---|
| 1650 | + | health care plans as described in Subsection A of this section |
---|
| 1651 | + | for compliance with the requirements of this section. If the |
---|
| 1652 | + | superintendent determines that a health care plan has not |
---|
| 1653 | + | .229151.1 |
---|
| 1654 | + | - 31 - underscored material = new |
---|
| 1655 | + | [bracketed material] = delete |
---|
1608 | | - | G. The superintendent shall annually audit all |
---|
1609 | | - | health care plans as described in Subsection A of this |
---|
1610 | | - | section for compliance with the requirements of this section. |
---|
1611 | | - | If the superintendent determines that a health care plan has |
---|
1612 | | - | not complied with the requirements of this section, the |
---|
1613 | | - | superintendent shall impose corrective action or use any |
---|
1614 | | - | other enforcement mechanism available to the superintendent |
---|
1615 | | - | to obtain the health care plan's compliance with this |
---|
1616 | | - | section. |
---|
| 1681 | + | complied with the requirements of this section, the |
---|
| 1682 | + | superintendent shall impose corrective action or use any other |
---|
| 1683 | + | enforcement mechanism available to the superintendent to obtain |
---|
| 1684 | + | the health care plan's compliance with this section. |
---|
1620 | | - | one prior authorization per plan period for any single drug |
---|
1621 | | - | or category of item enumerated in this section if prescribed |
---|
| 1688 | + | one prior authorization per plan period for any single drug or |
---|
| 1689 | + | category of item enumerated in this section if prescribed as |
---|
| 1690 | + | medically necessary by the subscriber's health care |
---|
| 1691 | + | practitioner. Changes in the prescribed dose of a drug; |
---|
| 1692 | + | quantities of supplies needed to administer a prescribed drug; |
---|
| 1693 | + | quantities of blood glucose self-testing equipment and |
---|
| 1694 | + | supplies; or quantities of supplies needed to use or operate |
---|
| 1695 | + | devices for which a subscriber has received prior authorization |
---|
| 1696 | + | during the plan year shall not be subject to additional prior |
---|
| 1697 | + | authorization requirements in the same plan year if prescribed |
---|
1623 | | - | practitioner. Changes in the prescribed dose of a drug; |
---|
1624 | | - | quantities of supplies needed to administer a prescribed |
---|
1625 | | - | drug; quantities of blood glucose self-testing equipment and |
---|
1626 | | - | supplies; or quantities of supplies needed to use or operate |
---|
1627 | | - | devices for which a subscriber has received prior |
---|
1628 | | - | authorization during the plan year shall not be subject to |
---|
1629 | | - | additional prior authorization requirements in the same plan |
---|
1630 | | - | year if prescribed as medically necessary by the subscriber's |
---|
1631 | | - | health care practitioner. Nothing in this subsection shall |
---|
1632 | | - | be construed to require payment for diabetes resources that HB 233/a |
---|
1633 | | - | Page 33 |
---|
| 1699 | + | practitioner. Nothing in this subsection shall be construed to |
---|
| 1700 | + | require payment for diabetes resources that are not covered |
---|
| 1701 | + | benefits. |
---|
| 1702 | + | I. The provisions of this section do not apply to: |
---|
| 1703 | + | (1) a short-term health care plan; |
---|
| 1704 | + | (2) an excepted benefit health care plan |
---|
| 1705 | + | intended to supplement major medical coverage, including |
---|
| 1706 | + | .229151.1 |
---|
| 1707 | + | - 32 - underscored material = new |
---|
| 1708 | + | [bracketed material] = delete |
---|
1671 | 1741 | | (1) means benefits for medically necessary |
---|
1672 | 1742 | | services consisting of preventive care, emergency care, |
---|
1673 | 1743 | | inpatient and outpatient hospital and physician care, |
---|
1674 | 1744 | | diagnostic laboratory and diagnostic and therapeutic |
---|
1675 | 1745 | | radiological services; and |
---|
1676 | 1746 | | (2) does not include services for alcohol or |
---|
1677 | 1747 | | drug abuse, dental or long-term rehabilitation treatment." |
---|
1678 | | - | SECTION 5. EFFECTIVE DATE.--The effective date of the |
---|
1679 | | - | provisions of this act is January 1, 2026. |
---|
| 1748 | + | SECTION 5. APPLICABILITY.--The provisions of this act |
---|
| 1749 | + | apply to self-insurance provided pursuant to the Health Care |
---|
| 1750 | + | Purchasing Act, individual and group health insurance policies, |
---|
| 1751 | + | health care plans, certificates of health insurance, managed |
---|
| 1752 | + | health care plans, contracts of health insurance, group health |
---|
| 1753 | + | plans provided through a cooperative, individual and group |
---|
| 1754 | + | health maintenance organization contracts, health benefit plans |
---|
| 1755 | + | and group health coverage that are offered, delivered or issued |
---|
| 1756 | + | for delivery, renewed, extended or amended in New Mexico on or |
---|
| 1757 | + | after January 1, 2026. |
---|
| 1758 | + | - 33 - |
---|
| 1759 | + | .229151.1 |
---|